Original article
Neuromuscular complications in patients given pavulon/sr (pancuronium bromide) during artificial ventilation

https://doi.org/10.1016/0303-8467(85)90060-5Get rights and content

Abstract

This paper reports on 12 patients in a 3-year period (from 1st July 1980 to 1st July 1983) who were treated with artificial ventilation and with the muscle relaxant pancuronium bromide (Pavulon®), over a period of 6 days or longer. After discontinuation of this drug these patients developed severe tetraparesis with areflexia, sometimes combined with disturbances of the extraocular and facial muscles and diffuse muscular atrophy, without sensory disturbances. Seven patients recovered completely after 2–5 months, two made an incomplete recovery and three died due to the primary disease. It is suggested that these neuromuscular complications were caused by prolonged high-dosage Pavulon treatment in combination with renal and hepatic disturbances and/or the use of aminogucosides.

References (11)

  • MF Roizen et al.

    Pancuronium bromide

    Arch Int Med

    (1978)
  • WLM Baird et al.

    The neuromuscular blocking properties of a new steroid compound, pancuronium bromide

    Brit J Anaesth

    (1967)
  • CD Blitt et al.

    Pancuronium and the patient with myasthenia gravis

    Anaesthesiology

    (1975)
  • LHDJ Booy

    Pancuronium and its metabolites

    Thesis

    (1981)
  • EIF Martens et al.

    A myasthenia-like syndrome and polyneuropathy. Complications of gentamycin therapy

    Clin Neurol Neurosurg

    (1979)
There are more references available in the full text version of this article.

Cited by (216)

  • Corticosteroids and neuromuscular blockers in development of critical illness neuromuscular abnormalities: A historical review

    2017, Journal of Critical Care
    Citation Excerpt :

    Historically, corticosteroids were administered in much higher doses than typically used today [3-9], with some patients receiving more than a gram of hydrocortisone a day [10]. Neuromuscular blockade was used more commonly in mechanically ventilated patients, with continuous infusions of 6 days or longer, for larger cumulative doses [6-8,11,12]. Although, recently, corticosteroids are prescribed less often and at lower doses, and NMB is no longer used routinely [13], steroids and NMB are still indicated in selected critically ill patients, such as the administration of NMB in severe acute respiratory distress syndrome (ARDS) [14-17].

  • Myopathies of Systemic Disease

    2015, Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician's Approach
  • Neuromuscular complications in intensive care patients

    2014, Handbook of Clinical Neurology
  • ICU acquired neuromyopathy

    2013, Annales Francaises d'Anesthesie et de Reanimation
View all citing articles on Scopus
View full text